Wu YL - Search Results

1

Allelic Context of EGFR C797X-Mutant Lung Cancer Defines Four Subtypes With Heterogeneous Genomic Landscape and Distinct Clinical Outcomes.

Lu C, Wei XW, Wang Z, Zhou Z, Liu YT, Zheng D, He Y, Xie ZH, Li Y, Zhang Y, Zhang YC, Huang ZJ, Mei SQ, Liu JQ, Guan XH, Deng Y, Chen ZH, Tu HY, Xu CR, Chen HJ, Zhong WZ, Yang JJ, Zhang XC, Mok TSK, Wu YL, Zhou Q. Lu C, et al. Among authors: wu yl. J Thorac Oncol. 2024 Apr;19(4):601-612. doi: 10.1016/j.jtho.2023.11.016. Epub 2023 Nov 20. J Thorac Oncol. 2024. PMID: 37981218 Free article.

2

KDR and Sema3 genes expression in bone marrow stromal cells and hematopoietic cells from leukemia patients and normal individuals.

Wang Z, Li Y, Wu X, Cheng S, Yang L, Wu Y. Wang Z, et al. Hematology. 2005 Aug;10(4):307-12. doi: 10.1080/10245330500072389. Hematology. 2005. PMID: 16085543

3

EGFR/KRAS mutations and gefitinib therapy in Chinese NSCLC patients.

Wang Z, Wu YL, Zhang GC, Zhou Q, Xu CR, Guo AL. Wang Z, et al. Among authors: wu yl. Onkologie. 2008 Apr;31(4):174-8. doi: 10.1159/000116736. Epub 2008 Mar 20. Onkologie. 2008. PMID: 18418018

4

Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.

Zhong W, Yang X, Bai J, Yang J, Manegold C, Wu Y. Zhong W, et al. Eur J Cardiothorac Surg. 2008 Jul;34(1):187-95. doi: 10.1016/j.ejcts.2008.03.060. Epub 2008 May 23. Eur J Cardiothorac Surg. 2008. PMID: 18457958 Review.

5

[Erlotinib in the Second/Third Line Treatment of Patients with Advanced Non-small Cell Lung Cancer.].

Huang Y, Yang J, Huang Y, Xu C, Zhou Q, Wang Z, Wu Y. Huang Y, et al. Zhongguo Fei Ai Za Zhi. 2009 May 20;12(5):412-6. doi: 10.3779/j.issn.1009-3419.2009.05.019. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20719136 Free article. Chinese.

6

[Analysis of Differentially Expressed Proteins in Self-Paired Sera of Advanced Non-small Cell Lung Cancer Patients Responsive to Gefinitib.].

Yang X, Zhang X, Yang J, Huang Y, Guo A, Lin J, An S, Tang H, Cheng S, Huang Y, Wu Y. Yang X, et al. Zhongguo Fei Ai Za Zhi. 2009 Jul 20;12(7):765-9. doi: 10.3779/j.issn.1009-3419.2009.07.018. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20719152 Free article. Chinese.

7

[The Impact of Smoking Status on the Efficacy of Erlotinib in Patients with Advanced Non-small Cell Lung Cancer.].

Huang Y, Yang J, Yang Y, Huang Y, Liao R, Wu Y. Huang Y, et al. Zhongguo Fei Ai Za Zhi. 2009 Dec 20;12(12):1266-70. doi: 10.3779/j.issn.1009-3419.2009.12.08. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20723381 Free article. Chinese.

8

[Detection of epidermal growth factor receptor mutations in non-small cell lung cancer tumor specimens from various ways by denaturing high-performance liquid chromatography].

Chen S, Chen Z, Guo A, Su J, Huang Y, Chen S, Zhang X, Yang X, Yang J, Wu Y. Chen S, et al. Zhongguo Fei Ai Za Zhi. 2010 Sep;13(9):850-5. doi: 10.3779/j.issn.1009-3419.2010.09.03. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20840812 Free PMC article. Chinese.

9

[VEGF-D expression in lung adenocarcinoma with or without acquired resistance to gefitinib and normal lung tissue].

Wang Z, Wu Y, Zhang G, Guo A, Su J, Chen Z. Wang Z, et al. Zhongguo Fei Ai Za Zhi. 2007 Dec 20;10(6):477-80. doi: 10.3779/j.issn.1009-3419.2007.06.06. Zhongguo Fei Ai Za Zhi. 2007. PMID: 21129303 Free article. Chinese.

10

[Optimizing the methods of whole lung cancer RNA-loaded dendritic cells].

Wang K, Wu Y, Zhou Q, Xu C, Lin J, Yang X, Huang S. Wang K, et al. Zhongguo Fei Ai Za Zhi. 2005 Dec 20;8(6):489-94. doi: 10.3779/j.issn.1009-3419.2005.06.01. Zhongguo Fei Ai Za Zhi. 2005. PMID: 21208534 Free article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,240 results

Search Page